Revance Therapeutics (RVNC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RVNC | VNDA | RCKT | ||
| Company | Revance Therapeutics | Vanda Pharmaceuticals | Rocket Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.65 | 6.76 | 3.49 | ||
| High | 3.66 | 6.94 | 3.63 | ||
| Low | 3.65 | 6.75 | 3.47 | ||
| Latest | 3.65 | 6.71 | 3.44 | ||
| Change | +0.01 | +0.06 | +0.02 | ||
| % Change | +0.27% | +0.90% | +0.58% | ||
| Volume | 4,123,100 | 131,742 | 1,136,801 | ||
| 20-Day Average Volume | 2,900,350 | 2,005,820 | 5,049,833 | ||
| Previous Close | 3.64 | 6.65 | 3.45 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.53 | 7.99 | 4.51 | ||
| 20-Day Raw Stochastic | 89.36% | 7.76% | 7.49% | ||
| 20-Day Relative Strength | 52.71 | 43.42 | 41.65 | ||
| Weighted Alpha | -53.44 | +14.66 | +10.76 | ||
| Today's Opinion | 24% Sell | 40% Buy | 24% Buy | ||
| Previous Opinion | 24% Sell | 40% Buy | 8% Buy | ||
| Last Month's Opinion | 88% Sell | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.27% since 01/29/25 | +0.17% since 03/24/26 | -17.21% since 03/24/26 | ||
| Low | 3.62 on 01/30/25 | 6.57 on 03/30/26 | 3.38 on 03/30/26 | ||
| High | 3.66 on 02/05/25 | 7.27 on 03/25/26 | 5.14 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | +18.12% since 01/03/25 | -23.33% since 02/27/26 | -29.44% since 02/27/26 | ||
| Low | 3.23 on 01/10/25 | 6.57 on 03/30/26 | 3.38 on 03/30/26 | ||
| High | 3.70 on 01/17/25 | 9.94 on 03/10/26 | 5.45 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | -37.50% since 11/05/24 | -2.96% since 12/26/25 | +1.58% since 12/26/25 | ||
| Low | 3.01 on 12/09/24 | 5.73 on 02/20/26 | 3.00 on 02/05/26 | ||
| High | 5.97 on 11/06/24 | 9.94 on 03/10/26 | 5.45 on 03/10/26 | ||
| 6-Month | |||||
| %Chg | +19.28% since 08/05/24 | +33.95% since 09/26/25 | +8.44% since 09/26/25 | ||
| Low | 2.80 on 08/07/24 | 4.27 on 11/07/25 | 2.81 on 11/21/25 | ||
| High | 6.65 on 08/19/24 | 9.94 on 03/10/26 | 5.45 on 03/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 381,023 | 393,068 | 375,929 | ||
| Shares Outstanding, K | 104,390 | 59,108 | 109,123 | ||
| Annual Sales | 234,040,000 | 216,110,000 | 0 | ||
| Annual Net Income | -323,990,000 | -220,470,000 | -223,120,000 | ||
| Last Quarter Sales | 59,880,000 | 57,220,000 | 0 | ||
| Last Quarter Net Income | -38,120,000 | -141,190,000 | -42,540,000 | ||
| 60-Month Beta | 0.90 | 0.55 | 0.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 11/07/24 | -0.46 on 02/11/26 | -0.38 on 02/26/26 | ||
| Latest Earnings Date | 02/26/25 | 05/06/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||